Introduction
While most Mycobacterium species are saprophytic, inhabiting varied terrestrial and aquatic environments, several are important human pathogens. Mycobacterium tuberculosis (Mtb), the etiologic agent of tuberculosis (TB), is the world's deadliest human pathogen. Other mycobacteria, like Mycobacterium leprae (causing leprosy), Mycobacterium ulcerans (causing Buruli ulcer) and opportunistic pathogens Mycobacterium abscessus and Mycobacterium avium, are continuing or emerging public health threats. Antibiotic treatments are limited by broad spectrum intrinsic resistance of Mycobacterium species (Nguyen and Thompson, 2006; Nguyen and Pieters, 2009) , and by mutations that generate resistance to approved treatments (Islam et al., 2017) .
In Mtb, like other mycobacteria, the unique cell envelope has long been recognized as a primary determinant of antibiotic resistance, but it alone, even though it plays a central role, is not able to provide full protection (Jarlier and Nikaido, 1994) . Sequencing of the Mtb H37Rv genome (Cole et al., 1998) identified many potential resistance determinants that act in synergy with the cell wall barrier (Nguyen and Thompson, 2006; Nguyen and Pieters, 2009) . The genome encodes proteins for drug-modifying enzymes, efflux pumps and target-modifying enzymes. Since resistance systems often compromise fitness (Wright, 2007; Andersson and Hughes, 2010; Gupta et al., 2013b) , their expression must be tightly controlled to induce during exposure to antibiotics. Activation of expression is often achieved by antibiotic-induced, transcriptional anti-termination within an upstream, untranslated region (5 0 -UTR) of resistance genes. This requires characteristic sequences in the 5 0 -UTR, including an open reading frame and a palindromic sequence forming a stem-loop structure (Dar et al., 2016; Dar and Sorek, 2017; Dersch et al., 2017) . These systems can have unexplained specificities for different classes of antibiotics (Dar et al., 2016) . Our work has focused on WhiB7, a central regulator of intrinsic antibiotic resistance that is conserved throughout the actinomycetes phyla. WhiB7 activates resistance to a broad range of antibiotics in all species analyzed, including Mtb, Mycobacterium bovis BCG, Mycobacterium smegmatis, Streptomyces lividans and Rhodococcus jostii RHA1 (Morris et al., 2005; Ramon-Garcia et al., 2013) . Our studies have established WhiB7 as an auto-regulatory transcriptional activator. In response to unknown signals, WhiB7 binds the primary vegetative sigma factor, SigA, and guides the RNA polymerase holoenzyme to genes in its regulon by targeting an AT-rich motif immediately upstream of their promoters through its C-terminal DNA binding AT-hook . While some essential components have been identified, the metabolic signal(s) and mechanisms that activate the WhiB7 resistance pathway have yet to be elucidated.
An array of antibiotics, as well as metabolic conditions, activate whiB7 expression (Geiman et al., 2006; Burian et al., 2012b) . Antibiotics that induce whiB7 are structurally diverse, often targeting different sites in the ribosome (Burian et al., 2012b) . Amino acid supplements and redox changes can modulate the level of antibiotic-induced whiB7 transcription (Burian et al., 2012b) . In the absence of antibiotics, whiB7 is induced by low iron conditions, ethanol, heat shock, various fatty acids and on entry into stationary phase (Morris et al., 2005; Geiman et al., 2006) . Many of these mimic stress conditions encountered by Mtb during invasion of macrophages when whiB7 is strongly induced (Homolka et al., 2010) . Together these data indicate coordinated regulation of whiB7 and suggest important contributions of yet unknown signals, activators, or repressors.
While basic discoveries in bacterial metabolism, gene regulation and drug resistance have traditionally relied on the mutagenesis and screening of limited numbers of isolated colonies for a growth phenotype, Tn-seq couples high-density transposon mutagenesis with next-generation sequencing to allow rapid, high-throughput screens for genes with conditionally essential functions (Barquist et al., 2013; van Opijnen and Camilli, 2013) . Tn-seq can provide important insights into how bacteria adapt to environmental changes. In this article, we screened for genes that can regulate the WhiB7-resistance pathway by coupling Tn-seq with antibiotic selection.
Results
Library construction and selection to probe genetic elements contributing to WhiB7-mediated resistance To identify genes that regulate the WhiB7-resistance pathway, we generated a transposon library in M. smegmatis and used Tn-seq to identify mutants that were depleted in cultures exposed to a set of WhiB7-specific antibiotics at concentrations below the minimum inhibitory concentration (MIC). While dispensable under regular growth conditions, amplified WhiB7 expression is essential to generate resistance to a wide array of antibiotics (Burian et al., 2012b) . Therefore, whiB7, and presumably any other elements contributing to its expression and/or function, would be essential for growth in the presence of antibiotics at concentrations that permit the growth of wild type (WT), but inhibit growth of a whiB7 knock-out mutant (DwhiB7). In addition, resistance genes dependent on WhiB7 would also become essential, as well as non-WhiB7 dependent resistance systems. To focus on genes needed for activation of WhiB7, structurally dissimilar WhiB7-specific antibiotics [roxithromycin (rox), chloramphenicol (cam) and tetracycline (tet)] were used individually for selection at concentrations that would only inhibit the DwhiB7 cultures (Supporting Information Fig. S1 ). It was expected that only regulators required for WhiB7 induction and function would be essential under all three conditions (Supporting Information Fig. S2 ).
M. smegmatis was mutagenized with UMycoMarT7 (Sassetti et al., 2001 ) to generate a library of transposon mutants ( 55 000 inserts as estimated by colony count). The transposon only inserts into TA sequences, with less than 10% of these sites being nonpermissive (DeJesus et al., 2017) . The library was used to inoculate fresh media at a starting OD 600 of 0.01 and incubated for 2 h before the addition of an antibiotic. Cultures were grown until stationary phase and genomic DNA isolated. High throughput sequencing was used to monitor changes in the frequencies of insertions at each TA site as a function of antibiotic exposure (the protocol is outlined in Supporting Information Fig. S3 ). Analysis of the untreated cultures indicated that the library represented about one third coverage ( 57 000 unique TA locations) of the 150 000 TA target sequences present in the M. smegmatis genome. Of the roughly 7000 annotated M. smegmatis genes, 1400 did not have an identifiable insertion. Studies in Mtb (Griffin et al., 2011; Zhang et al., 2012) suggest more than half ( 750) may be essential genes. The ESSENTIALS software (http://bamics2.cmbi.ru.nl/websoftware/essentials/ essentials_start.php) developed by Zomer and colleagues (2012) was used to map sequencing read frequency to annotated M. smegmatis genes. Candidate genes were then analyzed using UGENE (Okonechnikov et al., 2012) to determine the number of transposon insertions sites and their associated read counts.
Sequences upstream of whiB7 that modulate its transcription
We have previously established that expression of whiB7 in mycobacteria is driven from a single, antibiotic-inducible promoter located 350-450 base pairs upstream of the gene in mycobacteria (Burian et al., 2012b) . Expression of whiB7 is low in the absence of an antibiotic, and highly induced on antibiotic challenge (Burian et al., 2012b) . We observed the same kinetics when heterologous whiB7 promoters, including those from Mtb (Burian et al., 2012b) and Rhodococcus jostii (Supporting Information Fig. S4 ), were screened in M. smegmatis. This implies that the regulatory proteins and nucleotide motifs that modulate whiB7 transcription are conserved across actinobacteria.
RNA-seq studies in Mycobacterium marinum (Dinan et al., 2014) , Mycobacterium bovis (Dinan et al., 2014) , M. smegmatis (Shell et al., 2015) and Mtb (mtb. wadsworth.org) indicate that transcription of the whiB7 promoter is constitutive, but whiB7 is not expressed because of early termination of the transcript; in all cases transcript termination occurs a few base pairs downstream of a large palindrome. The palindrome is proposed to act as a Rho-independent transcriptional terminator (Dinan et al., 2014) . Our sequence analysis of M. smegmatis, M. marinum, Mtb and R. jostii shows the palindrome was always present upstream of whiB7 and its sequence was conserved (Fig. 1A) . Furthermore, a point mutation that increases whiB7 transcription is located within the palindrome (Reeves et al., 2013) . In addition to the palindrome, the region corresponding to the actively transcribed, early terminated transcript contains an unannotated, upstream open reading frame (uORF) (Dinan et al., 2014) .
The presence of a uORF was ubiquitous in the 5 0 UTR of whiB7 transcripts in all the mycobacteria and other actinobacteria that we have examined. Single nucleotide insertions or deletions in the whiB7 5 0 -UTR that increase whiB7 expression in Mtb (Reeves et al., 2013) all map to the uORF (Fig. 1B) . Ribo-seq analysis in Mtb and M. smegmatis both indicate that the uORF is actively translated in the absence of antibiotic (data freely accessible at mtb.wadsworth.org and smegmatis.wadsworth.org) (Shell et al., 2015) . This suggests that efficient in-frame translation of the uORF may serve to repress transcriptional readthrough, preventing whiB7 expression. Interestingly, the uORF peptide sequences are highly divergent, even across Mycobacterium species (Fig. 1C) ; this is in direct contrast to WhiB7 which has a highly conserved core sequence (Fig. 1D ). This suggests that the protein encoded by the uORF does not have a conserved function and implies it is the uORF sequence that is required for proper regulation.
To determine whether the M. smegmatis uORF sequence contributes to repression, we fused a GFP reporter to whiB7 5 0 -UTR N-terminal truncations or with an in-frame deletion of the uORF (Fig. 1E) . All of the constructs displayed increased levels of fluorescence relative to the reporter fused to the intact sequence, indicating a loss of repression (Fig. 1E) . Note that the reporters were carried on a plasmid in wild type M. smegmatis indicating that although an unmodified uORF was present in the genome, it did not complement the truncated alleles in trans. These results further suggested that the uORF sequence did not encode a functional protein, but rather that this sequence may be required for efficient early transcriptional termination. However, these data did not rule out the possibility that the multicopy reporter plasmid simply titrated away uORF protein, leading to de-repression.
To examine this, we constitutively expressed uORFs from M. smegmatis, Mtb and R. jostii in M. smegmatis, and monitored levels of antibiotic resistance. If the uORF encoded a conventional repressor of whiB7, a decrease in resistance to WhiB7-specific antibiotics was expected. However, no changes in resistance to the WhiB7-specific antibiotics rox, spectinomycin (spt), or cam were observed (Supporting Information Table S1 ). Resistance to drugs outside the WhiB7 spectrum was also not affected by uORF overexpression (Supporting Information Table S1 ). Collectively, the lack of sequence homology in heterologous uORFs, the absence of complementation in trans, and the fact that constitutive expression had no effect on antibiotic resistance, strongly suggested the uORF did not encode a functional protein, but rather that the presence of a uORF sequence in cis may be required for whiB7 repression.
These analyses showed that the 5 0 -UTR of whiB7 contained two main features, a non-coding uORF followed by a palindrome. Transcriptional termination immediately after the palindrome, and the requirement of the uORF sequence for repression, suggest that the uORF and palindrome likely form a riboregulatory attenuation system (Dar and Sorek, 2017; Dersch et al., 2017) .
Exposure to sub-MIC antibiotics selects against transposon insertions in the 5 0 -UTR of whiB7
We analyzed how the frequencies of inserts at TA targets within the whiB7 locus changed when the library was cultured in medium containing sub-MIC rox, cam, or tet. The whiB7 gene only contained a single TA near its C-terminus ( Fig. 2 ) which was not disrupted and, therefore, could not be analyzed (Supporting Information  Table S2 ). However, the whiB7 promoter is about 450 bases upstream of the gene, with the long 5 0 -UTR likely serving a regulatory function as described above. Since this region was intergenic, it was not analysed by ESSENTIALS which is restricted to annotated gene coordinates; we used UGENE to manually determine whether the antibiotics selected against inserts in the whiB7 5 0 -UTR. Multiple insertions were present within the whiB7 promoter and the 5 0 -UTR when no antibiotic selection was applied (Fig. 2) . The insertion at position #2 disrupts the WhiB7 binding site upstream of the promoter and should prevent amplification of the whiB7 transcript, while insertions #3-6 are located downstream of the promoter and expected to eliminate whiB7 transcription by polar effects. Insertions #1 and #7 are outside of areas required for whiB7 expression and, therefore, should not affect WhiB7-mediated resistance. As expected, insertions #2, #3, #5 and #6 either disappeared or showed very few read counts when the cultures were treated with any of the three sub- MIC antibiotics, while read counts at insertions #1 and #7 remained relatively unchanged. Surprisingly, an insertion within the uORF (#4; Fig. 2 ) may be beneficial for growth in the presence of cam or tet, as indicated by read count enrichment. Since point mutations in the uORF increase whiB7 transcription (Reeves et al., 2013) , the transposon insertion may have a similar effect. However, there was no enriched read count generated by rox selection, a condition where increased basal whiB7 expression should cause a growth advantage (Burian et al., 2012b) . This implies that these higher read counts may be artifacts due to unpredictable, random sequence bias affecting amplification. Together, these results confirmed that the whiB7 locus was conditionally essential under all three antibiotic treatment conditions, affirming our experimental conditions.
Candidate genes contributing to the WhiB7-specific antibiotic resistance phenotype A detailed description of the logic used to identify candidate genes contributing to WhiB7-specific resistance is provided in the Supplementary Methods. Briefly, while ESSENTIALS ranked results based on significantly lower read counts in cultures containing antibiotics, our sequencing method indicated a few disproportionate reads at unpredictable locations which varied in each condition (Supporting Information Fig. S5 ); these generated obvious false positive hits. To narrow down the candidates, we used manual mapping by UGENE to screen highly ranked ESSENTIALS calls to ensure the loci had consistently decreased transposon insertion frequencies after exposure to all of the antibiotics. In total, we identified six genes that may contribute to WhiB7 expression or function (Table 1) ; some of them encoded known antibiotic resistance determinants. Antigen 85 (MSMEG_6398) knock-out generates significant cell envelope perturbations which increase the rate of antibiotic penetration . Similarly, the ftsX (MSMEG_2090) deletion may also lead to cell wall perturbations (Mavrici et al., 2014) . Since the susceptibility changes mediated by disruption of these genes were likely due to increased antibiotic influx rather than dysregulation of WhiB7 activity, these hits were disregarded in this study. Additional genes that were identified included MSMEG_4269 (asnB), a known multi-antibiotic resistance determinant with an unknown mode of action (Ren and Liu, 2006) , as well as several hypothetical genes: MSMEG_3027, and the pair of potentially overlapping genes MSMEG_3637 and MSMEG_3638. Whether these hypothetical genes or asnB promote resistance through WhiB7 rather than independent mechanisms was investigated further.
Antibiotic susceptibilities of candidate gene deletion strains
Inactivation of potential whiB7 regulatory genes was expected to generate a WhiB7-specific susceptibility profile. To test this, gene deletion mutants were constructed for the genes identified by sub-MIC antibiotic treatments: MSMEG_3027 (D3027), MSMEG_3637/ MSMEG_3638 double mutant (D3637/8) and asnB (D4269). Rox, used for selection, as well as another WhiB7-specific antibiotic, spt, were used to screen for susceptibility changes of the mutants.
Of the three candidates, D3637/8 was the only one that had increased sensitivity to both rox and spt (Table 2) . Bioinformatic analysis of MSMEG_3637 and MSMEG_3638 showed that they are conserved across mycobacteria and are likely membrane associated, but they have not been linked to a proposed function. MSMEG_3027 and asnB either reflect false positives due to unpredictable limitations of the Tn-seq screen, or possible complex community interactions induced by antibiotic treatment which actively select against insertions within these genes. These interactions would not be present in a homogeneous mutant culture used for the MIC assay and, therefore, no difference in susceptibility would be observed.
Identification of MSMEG_4060 as a negative regulator of WhiB7-mediated resistance
We previously reported that pre-induction of whiB7 generates an antibiotic-adapted state resulting in increased MIC to macrolides, but does not affect other antibiotic resistances dependent on whiB7 (Burian et al., 2012b) ; this effect is restricted to macrolides because it is mediated by the Erm(38) ribosomal methyltransferase (Nash, 2003) . Therefore, mutations in genes leading to whiB7 preinduction (ex. removal of repression) should also yield a higher level of resistance to macrolides, but not to other antibiotics. To isolate mutants with an above-MIC resistance phenotype, we treated our library with 3-fold MIC of rox. As potential hits, we only considered genes that had at least 2 different insertion sites indicating high abundance of the mutant. Out of about 50 mapped insertions, only two candidates met these criteria.
MSMEG_0965, encoding the major surface porin protein MspA, had 6 insertions which mapped at multiple locations. mspA deletion results in a broad spectrum of antibiotic resistance due to decreased rate of antibiotic entry into the cell (Stephan et al., 2004) . This includes resistance to erythromycin (rox, which was used for selection, is a derivative of erythromycin), as well as ampicillin, cephaloridine, vancomycin and rifampin (Stephan et al., 2004) . While this hit confirmed our selective conditions did isolate resistance mutants, deletion of mspA provides resistance by limiting antibiotic penetration and not pre-induction of WhiB7 function.
Two insertions were mapped to each adjacent TA of a TATA sequence which was not within a protein-coding region in the reference M. smegmatis genome, but mapped downstream of MSMEG_4060. However, our analysis of this region revealed a sequence error in the reference genome. Four independently generated PCR amplicons of the region (three with 4060UF/4060UR and one with 261p4060_F/261p4060_R), sequenced by the Sanger method, showed that MSMEG_4060 contains a single nucleotide deletion (DG779). This led to a frame shift in the open reading frame which extended the MSMEG_4060 coding sequence to include the TATA insertion sites (Supporting Information Fig. S6 ). BlastP analysis of the protein encoded by extended open reading frame, against the UniProtKB/Swiss-Prot database, showed strong homology to an aspartate aminotransferase (25% identity, E-value 4 e-32).
To test whether MSMEG_4060 may influence WhiB7-mediated resistance, we constructed strains in which MSMEG_4060 was either constitutively expressed (4060-OE) or deleted (D4060). Similar to the experiments described above, we used rox and spt to determine whether the antibiotic sensitivity profiles of the stains overlapped with DwhiB7. D4060 showed a fourfold increase in rox resistance, but was unchanged in spt resistance relative to WT (Table 3) ; this confirmed the screen where transposon insertions in MSMEG_4060 were identified as having increased roxithromycin resistance, and suggested the effect may be WhiB7-related as the above-MIC Values represent the MIC (lg/ml) as measured for at least three independent recombineered colonies for candidate knock-outs, or three biologically independent samples for wild type and DwhiB7. phenotype was restricted to the macrolide rox. Constitutive expression of MSMEG_4060 decreased resistance to rox and also spt (Table 3) , further indicating MSMEG_4060 may be linked to WhiB7-mediated antibiotic resistance.
Expanded resistance profile of D3637/8 and 4060-OE strains
Our screens identified both the D3637/8 and 4060-OE strains as possibly having defects in WhiB7-mediated resistance. To further explore this hypothesis, we assayed their MICs using an expanded spectrum of antibiotics. The screen included drugs that fall into three categories: those within the WhiB7 susceptibility spectrum [rox, clarithromycin (cla), spt, cam, acivicin (aci)], those that induce whiB7 (Burian et al., 2012b) but are not within the susceptibility spectrum (amikacin (amk), linozelid (lnz), danofloxacin (dan)], and those that are not linked to either of these WhiB7 phenotypes [rifampicin (rif), and biapenem (bpm)]. In addition to wild type, DwhiB7, D3637/8 and 4060-OE strains, we also included a sigA mutant strain Sig515 . Sig515 contains the SigA R453H mutation which abolishes WhiB7-SigA interaction in vitro, and shows a WhiB7-like antibiotic sensitivity profile in vivo . M. smegmatis SigA R453H corresponds to the Mtb SigA R515H mutation known to destabilize WhiB3-SigA interaction (Steyn et al., 2002) . SigA R453H is currently the only mutation, outside of DwhiB7, known to affect WhiB7-mediated resistance.
The DwhiB7 strain was at least 4-fold more susceptible to rox, cla, spt, cam and aci compared to wild type (Table 4 ). This susceptibility spectrum was mirrored by the 4060-OE and Sig515 strains (Table 4) . While D3637/8 had DwhiB7-like susceptibility increases to rox, cla, spt and cam, it was not more susceptible to aci (Table 4) . For both the non-susceptibility spectrum antibiotics (amk, lnz, dan) and non-WhiB7 linked antibiotics (rif, bpm), all of the strains tested (DwhiB7, D3637/8, 4060-OE and Sig515) maintained wild type levels of resistance (Table 4 ). These correlations indicated that D3637/8 and 4060-OE susceptibility changes were restricted to antibiotics in the WhiB7-resistance spectrum and provided further evidence that they were likely linked to WhiB7-mediated resistance. However, the exception to this pattern, the observation that D3637/8 did not affect aci sensitivity, suggested MSMEG_3637/ 3638 and MSMEG_4060 may differ in the ways they regulate the WhiB7-pathway. Aci is unique in having pleotropic effects on metabolism including inhibiting translation, as well as inhibiting glutamine degradation, synthesis (transamidation) and utilization (Smulski et al., 2001) . This suggests that MSMEG_3637/3638 function may not be required to respond to secondary aciinduced metabolic stress.
4060-OE and 3637/8KO each had distinctive effects on whiB7 transcription
Antibiotic induced changes in transcription within the whiB7 locus were initially characterized in the wild type strain for comparison to 4060-OE and D3637/8. RT-qPCR quantification of uORF and whiB7 mRNA levels (Fig. 3A) allowed us to compare multiple changes in the whiB7 transcript resulting from antibiotic challenge. Values represent the MIC (mg/ml) as measured for at least three independent recombineered colonies for D4060, three independent transformants for 4060-OE, or three biologically independent samples for wild type and DwhiB7. Values represent the MIC (mg/ml) as measured for at least three independent recombineered colonies for D3637/8 and Sig515, three independent transformants for 4060-OE, or three biologically independent cultures for wild type and DwhiB7. a. One of the three SigA recombinants had an intermediate resistance of 500 lg/ml. Note, twofold changes are considered to be within the error margin of the MIC assay. Antibiotics include: roxithromycin (rox), clarithromycin (cla), spectinomycin (spt), chloramphenicol (cam), acivicin (aci), retapamulin (ret), amikacin (amk), linezolid (lnz), danofloxacin (dan), rifampicin (rif) and biapenem (bpm).
Our hypothesis was that the total level of whiB7 mRNA induction may reflect the contributions of two antibioticinduced changes; a WhiB7-mediated increase in whiB7 promoter activity which can be monitored by the levels of uORF mRNA, and a decrease in the efficiency of early termination which can be determined by monitoring the ratio of uORF to whiB7. PCR across the early termination junction performed on cDNA generated from RNA isolated from non-induced and antibiotic induced cultures (Supporting Information Fig. S7 ) confirmed RNA-seq data showing that the uORF and whiB7 were part of a single transcript (Burian et al., 2012b) . Representative whiB7 inducing antibiotics were analyzed in the wild type strain. Rox (Fig. 3B), cam (Fig. 3C) and aci (Fig. 3D) all induced whiB7 transcription, although with varied strengths (rox 450-fold, cam 60-fold and aci 20-fold). All three treatments led to a similar 3-5-fold decrease in the uORF:whiB7 ratio (Fig. 3E) . This confirmed that antibiotic treatment led to relaxed early termination which increased the amount of whiB7 transcript. The differences in total whiB7 induction strength between rox, cam and aci were primarily due to varied levels of promoter activation (rox 125-fold; Fig. 3F , cam 20-fold; Fig. 3G, and aci fourfold; Fig. 3H ). These results indicated that whiB7 induction was indeed the sum of two distinct changes in the whiB7 transcript; lowered efficiency of early termination and an increase in whiB7 promoter activity. Importantly, the data demonstrated that changes in whiB7 promoter activity were highly variable (4-125-fold), while the level of anti-termination was relatively constant (3-5-fold). This implies that early termination could be a binary on/off state. These observations held true when treatment concentration was varied (1/4 Fig. 3 . Effect of D3637/8 and 4060-OE on whiB7 induction in M. smegmatis.
A. Schematic representation of genomic locations targeted for RT-qPCR. Shown are the whiB7 promoter (P whiB7 ; black box with arrow), the uORF, the palindrome (hairpin) and whiB7. The sigA internal control is also shown. Primers used, their respective target locations, and amplicon sizes are indicated. Our previous studies using various macrolides established that whiB7 induction correlates with the stress induced by antibiotic exposure (Burian et al., 2012b) . Therefore, to generate a comparable stress response in strains having various drug susceptibilities, each strain was treated with an antibiotic concentration corresponding to their own MICs for three hours (Table 4) . B, C, and D. Fold increase of whiB7 mRNA relative to an untreated control of M. smegmatis wild type and its derivatives: MSMEG_3637/3638 double mutant (D3637/8), the MSMEG_4060 constitutive expression (4060-OE), and Sig R515H mutant (Sig515); treatments include (A) roxithromycin at MIC, (B) chloramphenicol at MIC and (C) acivicin at 66.6 lg/ml. E. Rate of early termination of the whiB7 transcript defined as the ratio of the uORF:whiB7 amplicons. Values are indicated for untreated (-), roxithromycin at MIC (rox), chloramphenicol at MIC (cam), and acivicin at 66.6 lg/ml (aci). F, G, and H. whiB7 promoter activity, defined as the fold increase of uORF mRNA relative to an untreated control, of each strain on treatment with (F) roxithromycin at MIC, (G) chloramphenicol at MIC and (H) acivicin at 66.6 lg/ml. In all cases values are the average of at least two biologically independent results measured in duplicate. Error bars represent standard deviation.
Regulatory genes that alter whiB7 transcription 409 MIC rox vs. MIC rox; Supporting Information Fig. S8 ). Corresponding studies were carried out to determine whether 4060-OE or D3637/8 had roles in promoter induction or anti-termination. The Sig515 mutant was included as an internal control to define the effects of restricting promoter induction by WhiB7.
Relative to wild type responses described above, antibiotic induction of whiB7 mRNA was severely impaired in both 4060-OE and D3637/8 on treatment with rox (Fig. 3B) or cam (Fig. 3C ). These observations held true when treatment concentration of rox was varied (1/4 MIC vs. MIC; Supporting Information Fig. S9) . In D3637/ 8, there was only a small increase in the whiB7 transcript, while 4060-OE showed no increase in the levels of whiB7 mRNA. The Sig515 mutant had a response very similar to that of D3637/8 (only rox treatment was tested; Fig. 3B ). While whiB7 induction by aci in D3637/ 8 was similar to the wild type (implicating an alternative system of regulation, see Discussion), induction was eliminated in 4060-OE (Fig. 3D) . The same qualitative trends were observed when uORF mRNA was assayed (Figs. 2F-H) to monitor antibiotic induced whiB7 promoter activity; induction of uORF mRNA was reduced in D3637/8 and no increase was observed in 4060-OE. Additional differences were observed in the ratio of uORF:whiB7, reflecting the rate of early termination. Whereas this ratio decreased similarly to the wild type in response to each of the antibiotics in D3637/8 and Sig515, it was unaffected in 4060-OE (Fig. 3E) . As WhiB7 is required to increase whiB7 promoter activity , sustained termination (i.e., blocked whiB7 expression) in 4060-OE explains the lack of promoter induction observed in Figs. 2F-G. In contrast, as D3637/8 showed wild type-like antibiotic induced changes in anti-termination, the decreased promoter induction in Figs. 2F-G was likely a result of an alternate mode of regulation. Together, the data demonstrated that MSMEG_4060 inhibited whiB7 transcription by irreversibly maintaining early termination, while MSMEG_3637 and/or MSMEG_3638 were required for optimal whiB7 promoter induction.
Discussion
Regulation of whiB7 is mediated by an interactive network that provides resistance to diverse antibiotics in actinobacteria. We have previously shown that WhiB7 directly activates transcription from its own promoter, and also found evidence for a WhiB7-independent partner(s) (Burian et al., 2012a,b; . In this study, we subjected a high-density transposon library to whiB7-specific antibiotic selection, and used high-throughput sequencing to identify genetic loci that have important roles in mediating WhiB7-activated resistance. Our data revealed that the gene pair MSMEG_3637/3638 (encoding hypothetical proteins) contributed to whiB7 expression, while MSMEG_4060, a putative aspartate aminotransferase, contributed to whiB7 repression. In addition, whiB7 regulation was dependent on two coordinated processes: early termination of the whiB7 transcript and increased activity of the whiB7 promoter.
The whiB7 transcript has a long 5 0 -UTR with two distinctive features, a uORF and a conserved palindrome (Figs. 1A and 2) . RNA-seq studies using various mycobacteria have demonstrated that without antibiotic exposure the whiB7 transcript is terminated early, immediately downstream of the palindrome (Dinan et al., 2014; Shell et al., 2015) . Upstream of the palindrome is a nonconserved uORF (Dinan et al., 2014) , which may be required for termination (Reeves et al., 2013) . Even though a uORF was encoded by all whiB7 5 0 -UTRs, its coding sequence was highly variable (Fig. 1C) implying that the uORF does not have a conserved function. Regulation of antibiotic resistance genes by transcriptional attenuation through translation of cis-acting, non-coding uORFs coupled to a stem-loop structure is a common mechanism in bacteria (Dar et al., 2016; Dar and Sorek, 2017; Dersch et al., 2017) . Insertion or deletion mutations in the uORF cause increased transcription of whiB7 in Mtb (Reeves et al., 2013) , possibly as a result of the change in the uORF translational stop site (Fig. 1B) . Similarly, our experiments indicate that deletion of the uORF or N-terminal 5 0 -UTR truncations cause increased transcription of whiB7 in M. smegmatis (Fig. 1E ). This suggests a possible mechanism for anti-termination could be either ribosome stalling and/or mistranslation within the uORF sequence. This would be similar to established modes of regulation of macrolide resistance genes (Ramu et al., 2009; Gupta et al., 2013a) . Together, these observations suggest that uORF was required for early transcriptional termination, but the encoded peptide does not have a function. We previously established that while maximal induction of whiB7 promoter by antibiotics requires WhiB7, a small increase does occur even in a whiB7 mutant (Burian et al., 2012b) . This implies that transcriptional induction of whiB7 can be split into at least two steps; anti-termination which increases whiB7 transcription (likely WhiB7 independent), followed by a very strong, WhiB7-mediated increase in promoter activity (Fig. 4) . We sought to identify proteins that regulate these steps by coupling Tn-seq studies with antibiotic selection.
Tn-seq studies of cultures exposed to three WhiB7-specific antibiotics at sub-MIC identified MSMEG_3637/ 3638 as a locus contributing to the WhiB7-mediated resistance pathway (Table 1) . Confirming these results, site directed mutagenesis of MSMEG_3637/3638 (D3637/8) resulted in decreased resistance to WhiB7-specific antibiotics (Table 4) , and a defect in transcriptional induction of whiB7 in response to rox and cam ( Fig. 3B and C) . While antibiotic induction of uORF mRNA was depressed, indicating a defect in whiB7 promoter activation ( Fig. 3F and G), anti-termination (the ratio of uORF/whiB7) was unaffected (Fig. 3E) . Nearly identical results were obtained from antibiotic induced cultures of the Sig515 mutant (Fig. 3B , E, and F) implying that deletion of MSMEG_3637/3638 may have a deleterious effect on WhiB7-SigA interaction. Bioinformatic analysis indicates that MSMG_3637/3638 were likely membrane associated, suggesting that their effect on transcription involved additional protein partners. Since strong induction of the whiB7 promoter requires WhiB7 (Burian et al., 2012b) , it is likely that MSMEG_3637/3638 exert their activity in a WhiB7-dependent rather than independent manner. This could occur by direct WhiB7 modification resulting in an increased ability of WhiB7 to promote transcription (Fig. 4) .
Intriguingly, while MSMEG_3637 and/or MSMEG_3638 had a role in regulating whiB7 promoter activity, and were required to enhance most WhiB7-dependent antibiotic resistance phenotypes, they were not involved in aci resistance (Table 4) . Relative to rox, aci was much less active in inducing transcription of the whiB7 gene (Figs. 2D and 3B; 450 vs. 20) , or increasing its promoter activity ( Figs. 2H and 3F ; 125 vs. 4) in wild type cells. In the case of rox, the D3637/8 mutant showed an increase in whiB7 promoter-driven transcription of 10-fold (Fig. 3F) . While a 10-fold increase in whiB7 promoter activity (Fig. 3F ) was insufficient to generate WhiB7-mediated rox resistance (Table 4) , a relatively small fourfold increase in transcription (Fig. 3H ) was sufficient for aci resistance (Table 4 ). These observations suggested that MSMEG_3637/3638 were only required to amplify WhiB7-mediated resistance if large increases in transcription were needed. The fact that disrupting WhiB7-SigA interaction resulted in aci susceptibility (Sig515 ; Table 4 ), but D3637/8 had wild type levels of resistance (Table 4 ), implies that MSMEG_3637/3638 are not essential for WhiB7 to bind SigA. MSMEG_3637/3638 may alter the strength of WhiB7-mediated transcription by increasing the affinity of WhiB7 to SigA, or modifying WhiB7 to increase its DNA binding. However, there also may be additional, yet-undiscovered regulators that each respond to a different set of antibiotics to enhance or repress the WhiB7 response. Tn-seq experiments, like the ones presented here, coupled with aci selection may uncover further intricacies in whiB7 regulation. Additional regulators were also uncovered with our Tn-seq studies that screened for mutants which were more resistant to macrolides.
Selection with rox at super-MIC enriched for Tn insertions in MSMEG_4060, providing the first evidence that this gene might serve to repress WhiB7-mediated antibiotic resistance (Table 3) . Constitutive expression of MSMEG_4060 (4060-OE) sensitized M. smegmatis to the same spectrum of antibiotics as a whiB7 deletion (Table 4) . Furthermore, analysis of the whiB7 transcript in 4060-OE under antibiotic induced conditions showed that constitutive expression of MSMEG_4060 completely eliminated transcriptional induction of whiB7 (Fig.  3A-C) . Analyses of the ratio of uORF:whiB7 in 4060-OE showed that unlike in the wild-type, D3637/8, and whiB7 uORF whiB7 uORF whiB7 uORF
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Step 2 transcription. Transcription of whiB7 is maintained at low levels due to early transcriptional termination at a large palindrome. Antibiotics, as well as other stressors, generate a signal which causes anti-termination leading to expression of WhiB7 (Step 1); anti-termination can be prevented by the activity of MSMEG_4060, a putative aspartate aminotransferase. Expression of WhiB7 (white circles) leads to a low increase in promoter activity by binding to SigA; WhiB7's activity can be strongly enhanced (Step 2; green circles) by the activity of MSMEG_3637 and/ or MSMEG_3638.
Sig515 strains, antibiotic treatment did not suppress the first step in our model of the induction cascade (Fig. 4) , i.e., early termination of the whiB7 transcript (Fig. 3D) . The lack of whiB7 expression due to sustained early termination would, therefore, block the second step of the induction cascade, i.e., antibiotic-induced, WhiB7-mediated increase in whiB7 promoter activity (Fig. 4) ; indeed, no increase in uORF mRNA was observed in 4060-OE on antibiotic challenge (Fig. 3F-G) . These results demonstrated that MSMEG_4060 inhibited antibiotic-induced whiB7 transcription by irreversibly maintaining early transcriptional termination. We believe that the mechanism by which a putative aspartate aminotransferase affects transcriptional regulation of whiB7 likely reflects metabolic signals and not direct regulation by DNA or RNA binding. DRNApred (Yan and Kurgan, 2017) analysis did not indicate DNA or RNA binding motifs in MSMEG_4060, while DP-bind (Hwang et al., 2007) did suggest several potential DNA binding sequences. BlastP analysis of the potential DNA binding sequences identified by DP-bind did not return hits of known transcriptional regulators, but mainly showed homology to parts of aspartate aminotransferases, arginine aminotransferases, or histidine-tRNA ligases. This suggests that MSMEG_4060 was likely an aminotransferase, and that the transcriptional effects on whiB7 would, therefore, be mediated by shifting metabolite concentrations. MSMEG_4060 was not conserved across all mycobacteria, implying that its regulatory influence on WhiB7 may not be a universal feature. However, mycobacteria and other actinobacteria have many homologous aminotransferases which may be adapted to MSMEG_4060-like roles, or perhaps serve as unique modulators of the WhiB7 pathway. Future metabolomics studies utilizing strains perturbed at different stages of the WhiB7 response (DwhiB7, D3637/8, Sig515 and 4060-OE) may reveal how antibiotic-triggered metabolic changes affect whiB7 regulation.
In the simplest model based on a common riboregulatory mechanism known to control resistance genes in other bacteria (Dar et al., 2016; Dar and Sorek, 2017; Dersch et al., 2017) , activation of whiB7 transcription in response to antibiotic-induced stress involves two distinct steps (Fig. 4) . Although the whiB7 promoter is constitutively active, under normal growth conditions expression of the whiB7 gene is maintained at low levels due to early termination of the transcript (Dinan et al., 2014; Shell et al., 2015) (Fig. 3E) . We found that exposure to antibiotics leads to anti-termination (Fig. 4, Step 1) which increases whiB7 expression (Fig. 3E) . Expression is further amplified by a strong, WhiB7-mediated increase in promoter activity (Fig. 4, Step 2). Our results also demonstrate that early termination can be irreversibly maintained by the putative aspartate aminotransferase MSMEG_4060 (Fig. 3E) , and that antibiotic stress signal(s) may be integrated by regulators such as MSMEG_3637/3638 to amplify the strength of WhiB7-mediated transcriptional activation ( Fig. 3F and G) . Studies of WhiB7 dependent intrinsic antibiotic resistance in pathogenic mycobacteria may allow more effective uses of drug combinations (Ramon-Garcia et al., 2011) or the development of novel drugs for the treatment of mycobacterial diseases including TB. 
